Form 4: Sabra REIT Director Receives Dividend Equivalent Stock Units

Sabra Health Care REIT, Inc. Director Craig A. Barbarosh was credited with 813 common stock units as dividend equivalent payments on existing awards.

Summary

• Craig A. Barbarosh, a Director of Sabra Health Care REIT, Inc. (SBRA), acquired 813 shares of common stock.
• These shares were credited as dividend equivalent payments on previously granted stock units under the Issuer's 2009 Performance Incentive Plan.
• The acquisition occurred on August 29, 2025, at a price of $0, reflecting the nature of dividend equivalents.
• Following this transaction, Mr. Barbarosh directly beneficially owns 52,610 shares of common stock.
• Additionally, 94,916 shares are indirectly beneficially owned by The Barbarosh Family Trust.
• The directly owned 52,610 shares consist of 6,922 unvested stock units and 45,688 vested but deferred stock units, each representing the right to receive one share of common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The filing is neutral to slightly positive, indicating routine insider activity that aligns director interests with shareholders through equity compensation and dividend equivalents. It does not contain any significant new operational or financial news.

Positives

• The acquisition of 813 stock units by a director indicates continued alignment of management interests with shareholder interests through equity ownership.
• The dividend equivalent payments reflect the company's ongoing dividend distribution policy, which is generally positive for income-focused investors.
• The transaction being under a Rule 10b5-1(c) plan suggests a pre-planned, non-discretionary acquisition, reducing concerns about opportunistic timing.

Risks

• The value of the stock units is tied to the market value of Sabra Health Care REIT, Inc.'s common stock, exposing the director to market fluctuations.
• The vesting and payment of these units are subject to the terms of the original stock units, which may include performance conditions or continued service requirements.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the vesting terms of the stock units. The units will vest and become payable on the same terms as the original stock units to which they relate.

Industry Context

This is a routine insider transaction for a director of a healthcare REIT. Such transactions are common in the industry as part of executive compensation and director remuneration, aligning interests with shareholders. REITs often pay dividends, and dividend equivalent units are a standard way to compensate directors with equity while maintaining their proportional ownership.

Comparison to Industry Standards

• The practice of granting dividend equivalent units to directors is a common compensation mechanism across the REIT sector and broader public companies, aligning director incentives with shareholder returns.
• Many companies, including peers like Ventas (VTR) or Welltower (WELL), utilize similar equity-based compensation plans for their directors, often including dividend equivalents on unvested or deferred awards.
• The use of a Rule 10b5-1 plan for such transactions is standard best practice for insiders to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders: The transaction reinforces alignment between a director and shareholders, as the director's equity stake increases with dividend equivalents, tying their financial interests to the company's performance and dividend policy.

Next Steps

• The acquired stock units will vest and become payable on the same terms as the original stock units to which they relate.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary acquisition of stock units by a director as dividend equivalents. It provides no new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment thesis. The transaction is a standard part of director compensation and aligns insider interests with shareholders, which is generally positive but not a catalyst for a "buy" or "sell" recommendation. Therefore, a "hold" recommendation is appropriate as this filing does not alter the fundamental outlook for Sabra Health Care REIT, Inc.

Keywords

Sabra Health Care REIT, SBRA, Form 4, Insider Transaction, Director Stock Acquisition, Dividend Equivalent, Stock Units, Craig A. Barbarosh, REIT, Healthcare REIT